{"id":"W2810970248","doi":"10.3324/haematol.2017.185991","title":"A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"Takeda Oncology","keywords":"Ixazomib; Medicine; Melphalan; Prednisone; Multiple myeloma; Maintenance therapy; Internal medicine; Adverse effect; Surgery; Lenalidomide; Chemotherapy; Carfilzomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005707502,0.0005071486,0.0009783105,0.0003464924,0.0003727189,0.00007208395,0.0002459702,0.000275522,0.00016425],"category_scores_gemma":[0.0009529699,0.0003997912,0.0001639042,0.0006963434,0.0002705406,0.0003023759,0.0001134994,0.0004252613,0.0001208124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000310372,"about_ca_system_score_gemma":0.0001136339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001168201,"about_ca_topic_score_gemma":0.001376622,"domain_scores_codex":[0.9960208,0.0003828724,0.0009120452,0.0009491174,0.0007063241,0.001028867],"domain_scores_gemma":[0.9981769,0.0002792483,0.0002797658,0.0005608607,0.0001852769,0.0005179485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009119419,0.02948435,0.6853674,0.0002141745,0.0006368076,0.00427804,0.00878144,0.00001754485,0.2178824,0.00003964165,0.007300871,0.0368779],"study_design_scores_gemma":[0.2558529,0.04846974,0.4914957,0.00180042,0.0007990853,0.001344096,0.006000483,0.02844972,0.1598158,0.0004095495,0.003485723,0.002076812],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943982,0.0002010479,0.0003612377,0.001072522,0.0002135532,0.00300598,0.00006605373,0.0002698764,0.000411486],"genre_scores_gemma":[0.9955547,0.00005679845,0.002759102,0.0002725882,0.000119248,0.0005163488,0.0004323403,0.00005564685,0.0002332606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2467335,"threshold_uncertainty_score":0.9998454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08065535250103235,"score_gpt":0.3476845975581068,"score_spread":0.2670292450570745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}